by McKesson Ventures | Jun 6, 2023 | Media Coverage, Press Releases
McKesson Ventures has participated in a $17.5 million Series A round for RxLightning, a platform for streamlining access and affordability for specialty medications. This brings the total the company has raised since its inception to $20.5 million. With RxLightning,...
by McKesson Ventures | Jun 29, 2022 | Media Coverage, Press Releases
Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...
by McKesson Ventures | Jun 17, 2022 | Press Releases
McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and...
by McKesson Ventures | Feb 7, 2022 | Press Releases
Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing...
by McKesson Ventures | Jan 25, 2022 | Press Releases
Technology-enabled service provider Reimagine Care is a leader in promoting support for oncologists by delivering valuable, home-centered cancer care. It recently announced that a $25 million capital raise has been completed. Led by LRVHealth, Santé Ventures, and...
